Bio-Techne: Bio-Techne's Q3 2025 Earnings: What to Expect
Bio-Techne is scheduled to release its fiscal third-quarter earnings next month, and analysts project a low single-digit bottom-line rise.
Read full article »
Bio-Techne is a Minnesota-based life science firm that manufactures products such as antibodies and bioactive reagents for the research and clinical diagnostic applications.
Read more